Robert Bostwick

849 total citations
21 papers, 361 citations indexed

About

Robert Bostwick is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Robert Bostwick has authored 21 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Robert Bostwick's work include Mosquito-borne diseases and control (4 papers), Virology and Viral Diseases (3 papers) and Ion channel regulation and function (3 papers). Robert Bostwick is often cited by papers focused on Mosquito-borne diseases and control (4 papers), Virology and Viral Diseases (3 papers) and Ion channel regulation and function (3 papers). Robert Bostwick collaborates with scholars based in United States, United Kingdom and Netherlands. Robert Bostwick's co-authors include Lynn Rasmussen, E. Lucile White, Corinne E. Augelli‐Szafran, Indira Padmalayam, A K Robbins, Joseph A. Maddry, Ling Zhai, Maire Peters, Per-Eric Lund and Olof Larsson and has published in prestigious journals such as PLoS ONE, Biochemical Journal and Journal of Medicinal Chemistry.

In The Last Decade

Robert Bostwick

19 papers receiving 350 citations

Peers

Robert Bostwick

MB

ID

PHEOH

CTM

CMN

Audrey L. Warren United States

Nikhil Kumar Tulsian Singapore

Indira Padmalayam United States

Bowen Jin China

Ling Yuan China

Bertrand Arnou France

Sonia Mediouni United States

Yafei Qu China

Jordan Wilkins United States

Samantha Mackin United States

Audrey L. Warren United States

Robert Bostwick

120 ×0.7

MB

82 ×0.8

ID

95 ×1.5

PHEOH

22 ×0.4

CTM

50 ×1.1

CMN

Citations per year, relative to Robert Bostwick Robert Bostwick (= 1×) peers Audrey L. Warren

Countries citing papers authored by Robert Bostwick

Since Specialization

Citations

This map shows the geographic impact of Robert Bostwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Bostwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Bostwick more than expected).

Fields of papers citing papers by Robert Bostwick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Bostwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Bostwick. The network helps show where Robert Bostwick may publish in the future.

Co-authorship network of co-authors of Robert Bostwick

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Bostwick. A scholar is included among the top collaborators of Robert Bostwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Bostwick. Robert Bostwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Nguyen, Theresa, Jessica R. Smith, Joanne Kivela Tillotson, et al.. (2025). Targeting west nile virus replication by xanthine inhibitors. Medicinal Chemistry Research. 34(12). 2558–2582.

2.

Moukha‐Chafiq, Omar, Hollis S. Kezar, Sixue Zhang, et al.. (2025). Discovery of a Chiral 2,4-Substituted Pyrrolo[2,3-d]pyrimidine as a Potent, Selective, and Orally Bioavailable LRRK2 Inhibitor. Journal of Medicinal Chemistry. 68(10). 9926–9946.

3.

Rasmussen, Lynn, et al.. (2023). High-Throughput cell-based immunofluorescence assays against influenza. SLAS DISCOVERY. 29(1). 66–76. 4 indexed citations

4.

Robinson, Carolyn, Terri D. Lyddon, David T. Evans, et al.. (2022). Novel Compound Inhibitors of HIV-1NL4-3 Vpu. Viruses. 14(4). 817–817. 4 indexed citations

5.

Zhang, Sixue, Atefeh Garzan, Nicole N. Haese, et al.. (2021). Pyrimidone inhibitors targeting Chikungunya Virus nsP3 macrodomain by fragment-based drug design. PLoS ONE. 16(1). e0245013–e0245013. 26 indexed citations

6.

Chen, Catherine Z., Paul Shinn, Zina Itkin, et al.. (2021). Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2. Frontiers in Pharmacology. 11. 592737–592737. 61 indexed citations

7.

Robin, Arthur, Alexander Chemodanov, Mario Lebendiker, et al.. (2021). Fighting SARS-CoV-2 with green seaweed Ulva sp. extract: extraction protocol predetermines crude ulvan extract anti-SARS-CoV-2 inhibition properties in in vitro Vero-E6 cells assay. PeerJ. 9. e12398–e12398. 15 indexed citations

8.

Piazza, John T., Kanupriya Whig, Ling Zhai, et al.. (2020). Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics. PLoS ONE. 15(12). e0243901–e0243901. 2 indexed citations

9.

Nguyen, Theresa, Nicole N. Haese, Nikhil Reddy Madadi, et al.. (2019). Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus. ACS Infectious Diseases. 5(12). 2014–2028. 3 indexed citations

10.

Zhang, Yinfeng, Lynn Rasmussen, Indira Padmalayam, et al.. (2019). Discovery of novel inhibitors of ribosome biogenesis by innovative high throughput screening strategies. Biochemical Journal. 476(15). 2209–2219. 20 indexed citations

11.

Varga, John, Derek Parsonage, William G. Walton, et al.. (2018). Identification of Specific and Nonspecific Inhibitors of Bacillus anthracis Type III Pantothenate Kinase (PanK). ChemMedChem. 14(1). 78–82. 4 indexed citations

12.

Goebel, Scott J., Beth A. Snyder, Timothy J. Sellati, et al.. (2016). A sensitive virus yield assay for evaluation of Antivirals against Zika Virus. Journal of Virological Methods. 238. 13–20. 33 indexed citations

13.

Zhang, Wei, Ling Zhai, Yimin Wang, et al.. (2016). Discovery of a novel inhibitor of kinesin-like protein KIFC1. Biochemical Journal. 473(8). 1027–1035. 37 indexed citations

14.

Rasmussen, Lynn, Bersabeh Tigabu, E. Lucile White, et al.. (2015). Adapting High-Throughput Screening Methods and Assays for Biocontainment Laboratories. Assay and Drug Development Technologies. 13(1). 44–54. 8 indexed citations

15.

Cochran, J. Nicholas, Lynn Rasmussen, E. Lucile White, et al.. (2014). AlphaScreen HTS and Live-Cell Bioluminescence Resonance Energy Transfer (BRET) Assays for Identification of Tau–Fyn SH3 Interaction Inhibitors for Alzheimer Disease. SLAS DISCOVERY. 19(10). 1338–1349. 18 indexed citations

16.

Liu, Jay, et al.. (2010). Advances in functional assays for high-throughput screening of ion channels targets. Expert Opinion on Drug Discovery. 5(10). 995–1006. 7 indexed citations

17.

Liu, Jay, et al.. (2008). A High-Throughput Functional Assay for Characterization of γ -Aminobutyric Acid _A Channel Modulators Using Cryopreserved Transiently Transfected Cells. Assay and Drug Development Technologies. 0(0). 3527819937–6. 1 indexed citations

18.

Liu, Jay, et al.. (2008). A High-Throughput Functional Assay for Characterization of γ -Aminobutyric Acid _A Channel Modulators Using Cryopreserved Transiently Transfected Cells. Assay and Drug Development Technologies. 6(6). 781–786. 20 indexed citations

19.

Dekermendjian, Kim, Jian Huang, Per-Eric Lund, et al.. (2007). Cellular HTS Assays for Pharmacological Characterization of Na _V 1.7 Modulators. Assay and Drug Development Technologies. 6(2). 167–179. 38 indexed citations

20.

Corradi, John, A K Robbins, Maire Peters, et al.. (2005). Alternative transcripts and evidence of imprinting of GNAL on 18p11.2. Molecular Psychiatry. 10(11). 1017–1025. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact